Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
26 Apr Dr. Reddys to release Q4 and Full Year FY16 results on May 12, 2016 // Earnings call slated for May 12, 6.30 PM IST / 9.00 AM EDT
24 Apr Closure of Trading Window
19 Apr FY16 results on May 12, 2016
19 Apr ZEMBRACE" SymTouch" (sumatriptan injection) 3 mg, approved by the FDA in January 2016 for the acute treatment of migraine with or without aura in adults, is now commercially available in the U.S.
19 Apr Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016
12 Apr Buy Back Offer
07 Apr Result of Postal Ballot
02 Apr Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
31 Mar Dr. Reddys Laboratories Acquires the Rights to Investigational Anticancer Agent E7777 for U.S, Europe and Certain Emerging Markets from Eisai
28 Mar Dr. Reddys Laboratories and XenoPort Enter Into a U.S. Licensing Agreement for XP23829
View announcements for all companies
Next >